Sub Banner Image

A $1.3 Billion Reason to Buy Eli Lilly Stock Now

Equities

Ruchi Gupta

·

June 20, 2025

·

Barchart

Eli Lilly has just acquired gene-editing company Verve Therapeutics.

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.